ANI Pharmaceuticals (ANIP)

[jacob613]

I need to peruse the post restructured MNK balance sheet more closely, but I’m not sure that it has such tremendous financial“flexibility” like a MSFT to just cut prices 50% + to drive away competition. They need CORTI whole dollar profits to service interest last I checked. But let’s play: let’s say market size is 500mm at ~20k a vial (down 50%) and Ani offers at 10k as per AP (prices down 1/2), so if ANI Gets 30% of market thats 75mm revenues and at least $50mm ebitda. That brings EBITDA to $130mm which means stock is trading 4.5x’s ebitda. If the stock revals back to 7.5x, that’s $71 pt